InvestorsHub Logo
Followers 33
Posts 2871
Boards Moderated 1
Alias Born 10/24/2015

Re: None

Monday, 05/13/2024 3:30:39 PM

Monday, May 13, 2024 3:30:39 PM

Post# of 154
(OT) Last week, Tome Bio dis­closed its pipeline for the first time. Its two most ad­vanced pro­grams are a pair of off-the-shelf cell ther­a­pies for au­toim­mune kid­ney dis­eases, in­clud­ing lu­pus nephri­tis. The en­gi­neered NKs are among the most heav­i­ly edit­ed, with three genes knocked out and four to five genes added.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NKTX News